Invention Grant
US07683067B2 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)
失效
作为糖原合酶激酶-3（GSK-3）抑制剂的3-杂环基 - 吲哚衍生物
- Patent Title: 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)
- Patent Title (中): 作为糖原合酶激酶-3（GSK-3）抑制剂的3-杂环基 - 吲哚衍生物
-
Application No.: US10572778Application Date: 2004-09-21
-
Publication No.: US07683067B2Publication Date: 2010-03-23
- Inventor: Stefan Berg , Sven Hellberg
- Applicant: Stefan Berg , Sven Hellberg
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agent Kenneth F. Mitchell
- Priority: SE0302546 20030924
- International Application: PCT/SE2004/001363 WO 20040921
- International Announcement: WO2005/027823 WO 20050331
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K31/4439 ; C07D401/14 ; C07D401/04
Abstract:
Compounds of formula Ia or Ib wherein P; R1; R2; m; and n are as defined in the application, salts thereof, processed for their preparation, new intermediates used therein, pharmaceutical formulations containing said compounds and the use of said compounds in therapy.
Public/Granted literature
- US20080275041A1 3-Heterocyclyl-Indole Derivatives as Inhibitors of Glycogen Synthase Kinase-3 (Gsk-3) Public/Granted day:2008-11-06
Information query
IPC分类:
